LifeNet Health

LifeNet Health is a non-profit global leader in regenerative medicine, headquartered in Virginia Beach, Virginia, USA. Founded in 1982 as the Eastern Virginia Tissue Bank, it became LifeNet in 1989 and LifeNet Health in 2007. As a private entity, LifeNet Health reported revenues of approximately $598.5 million in 2024 and employs around 1,200 to 1,700 individuals.

The organization is a federally designated organ procurement organization for Virginia and one of the world's largest providers of allograft bio-implants and organs for transplantation. LifeNet Health's operations encompass organ procurement, tissue banking, and the processing and distribution of human allograft tissues and cellular therapies. Their bio-implants are used in diverse surgical disciplines, including sports medicine, spine, cardiac, vascular, skin and wound care, craniomaxillofacial, orthopedics, and trauma. Through its LifeSciences Division, the company also supplies human biospecimens and primary cells for biomedical research and drug discovery.

LifeNet Health appears to be an operating company that actively defends its intellectual property while also asserting it. The company has been a defendant in two tracked patent cases, including challenges by Unified Patents and Embody Inc. before the Patent Trial and Appeal Board (PTAB). Concurrently, LifeNet Health has acted as a plaintiff in one tracked case, asserting its patents against Zimmer Biomet Holdings Inc. et al. in the Virginia Eastern District Court. This litigation posture indicates a company focused on both protecting and enforcing its patented technologies related to regenerative medicine and allograft solutions.

Notable technologies developed by LifeNet Health, which may be reflected in their patent portfolio, include Allowash XG for sterile tissue processing, Preservon for room-temperature graft storage, Matracell for decellularized tissue scaffolds, and the Nexeon Advanced Vascular Allograft.